Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-07-11)Premium Content

Sanofi (SNY)

2014-07-23@09:20:00 ET
Pharma Stocks under Review -- Impax Laboratories, Sanofi, GW Pharma, AcelRx Pharma, and Salix Pharma (PRN)

2014-07-22@12:28:42 ET
Sanofi-Aventis Crosses Above its 10-day MA (SNY) (F78)

2014-07-22@08:45:00 ET
Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States (PRN)

2014-07-17@08:28:25 ET
Valeant Pharmaceuticals International is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (VRX, PFE, PRGO, AGN, SNY) (F70)

2014-07-01@09:00:00 ET
CureVac Signs an Exclusive License Agreement with Sanofi Pasteur to Develop and Commercialize an mRNA-based Prophylactic Vaccine (PRN)

2014-06-26@13:30:52 ET
Shares of Sanofi-Aventis Under Pressure, Down 1.3% (F77)

2014-06-20@16:02:59 ET
Sector Update: Healthcare Stocks Rally on M&A Speculation; Kite Pharma Soars in Market Debut (MID)

2014-06-20@16:01:35 ET
Sector Update: Healthcare (MID)

2014-06-20@13:55:17 ET
Sector Update: Healthcare Stock Posting Strong Advance; Cara Therapeutics Jump 17% as Painkiller Trial Begins (MID)

2014-06-20@13:53:57 ET
Sector Update: Healthcare (MID)

2014-06-20@08:47:35 ET
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Impax Laboratories (IPXL, VVUS, ABT, SNY, SLXP) (F70)

2014-06-19@16:59:45 ET
Sanofi-Aventis Rises 1.23% on Heavy Volume: Watch For Potential Pullback (PSM)

2014-06-19@16:59:12 ET
Sanofi-Aventis Rises 1.23% on Heavy Volume: Watch For Potential Pullback (PSM)

2014-06-19@14:13:54 ET
Sanofi-Aventis Trading Higher on 4.2x Above-Average Volume (SNY) (F82)

2014-06-14@13:02:00 ET

2014-06-14@13:02:00 ET

2014-06-14@13:02:00 ET

2014-06-14@10:12:37 ET
Sanofi and Medtronic to Form Strategic Alliance in Diabetes to Improve Patient Experience and Outcomes (PMZ)

2014-06-12@01:00:00 ET
Sanofi and Regeneron Announce New, Detailed Data from Positive Sarilumab Phase 3 Rheumatoid Arthritis Trial at EULAR (PRN)

2014-06-11@14:04:25 ET
Sanofi-Aventis's Shares Changing Hands at Lower Prices on 2.3x Above-Average Volume (SNY) (F82)